HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mirjam Schuchardt Selected Research

i-cholesterol

1/2017High density lipoprotein (HDL) particles from end-stage renal disease patients are defective in promoting reverse cholesterol transport.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mirjam Schuchardt Research Topics

Disease

7Chronic Renal Insufficiency
05/2016 - 02/2012
5Vascular Calcification
12/2021 - 02/2012
5Chronic Kidney Failure (Chronic Renal Failure)
01/2017 - 02/2007
4Cardiovascular Diseases (Cardiovascular Disease)
04/2019 - 01/2010
3Arteriosclerosis
04/2019 - 01/2014
3Atherosclerosis
04/2012 - 03/2007
2Inflammation (Inflammations)
01/2021 - 04/2019
2Neoplasms (Cancer)
06/2017 - 01/2015
2Hypertension (High Blood Pressure)
01/2017 - 01/2015
2Vascular Diseases (Vascular Disease)
01/2014 - 01/2012
1Niemann-Pick Diseases (Niemann Pick Disease)
12/2021
1Porcine Reproductive and Respiratory Syndrome (PRRS)
01/2021
1Chronic Limb-Threatening Ischemia
01/2021
1Infections
07/2020
1Type 2 Diabetes Mellitus (MODY)
01/2018
1Myocardial Infarction
06/2017
1Stroke (Strokes)
06/2017
1Hyperuricemia
01/2017
1Diabetes Mellitus
09/2015
1Macular Degeneration (Age-Related Maculopathy)
01/2015
1Retinal Vein Occlusion
01/2015
1Diabetic Retinopathy (Retinopathy, Diabetic)
01/2015
1Dyslipidemias (Dyslipidemia)
01/2015
1Eye Diseases (Eye Disease)
01/2015
1Cardiomegaly (Heart Hypertrophy)
09/2009
1Diastolic Heart Failure
09/2009

Drug/Important Bio-Agent (IBA)

2AcidsIBA
12/2021 - 01/2017
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 04/2019
2HDL CholesterolIBA
01/2017 - 04/2012
2CholesterolIBA
01/2017 - 03/2007
2EnzymesIBA
01/2017 - 02/2007
2HDL LipoproteinsIBA
01/2017 - 01/2015
2Cystatin CIBA
05/2016 - 10/2012
2Proteins (Proteins, Gene)FDA Link
01/2015 - 04/2012
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
04/2012 - 08/2011
1Cholecalciferol (Vitamin D3)FDA Link
12/2021
1Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
12/2021
1Phosphates (Orthophosphate)IBA
12/2021
1CeramidesIBA
12/2021
1Pattern Recognition ReceptorsIBA
01/2021
1calcium phosphateIBA
01/2021
1AntibodiesIBA
07/2020
1NicotineFDA Link
04/2019
1Insulin ReceptorIBA
01/2018
1Doxycycline (Periostat)FDA LinkGeneric
01/2018
1Antihypertensive Agents (Antihypertensives)IBA
06/2017
1Xanthine OxidaseIBA
01/2017
1Uric Acid (Urate)IBA
01/2017
1Lipoproteins (Lipoprotein)IBA
01/2017
1i-cholesterolIBA
01/2017
1Biological ProductsIBA
01/2017
1Iohexol (Omnipaque)FDA Link
08/2015
1LipidsIBA
01/2015
1Uremic ToxinsIBA
01/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2015
1Pharmaceutical PreparationsIBA
01/2014
1Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric
01/2014
1CreatinineIBA
10/2012
1CytokinesIBA
04/2012
1Purinergic Receptors (Receptors, Purine)IBA
02/2012
1MitogensIBA
02/2012
1Purinergic AgentsIBA
02/2012
1uridine adenosine tetraphosphateIBA
02/2012
1MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA
02/2012
1Purinergic P2Y ReceptorsIBA
01/2012
1Phospholipases (Phospholipase)IBA
01/2010
1ProstaglandinsIBA
01/2010
1IsoprostanesIBA
01/2010
1Secretory Phospholipases A2IBA
01/2010
1CalcineurinIBA
09/2009
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
09/2009
1CollagenIBA
09/2009
1Nitric Oxide Synthase (NO Synthase)IBA
09/2009
1Phosphotransferases (Kinase)IBA
09/2009
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
03/2007
1Fingolimod Hydrochloride (FTY720)FDA Link
03/2007
1ApolipoproteinsIBA
03/2007
1Peptides (Polypeptides)IBA
02/2007
1AngiotensinsIBA
02/2007

Therapy/Procedure

4Therapeutics
01/2017 - 01/2015
1Organ Transplantation
01/2014
1Lasers (Laser)
02/2007